医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

LifestyledAI, Dongguk University Startup Technology Institute, and UMUST R&D Partner to Advance Global AI Deep Tech and Healthcare Businesses

2024年09月13日 PM10:00
このエントリーをはてなブックマークに追加


 

SEOUL, South Korea

On August 28, 2024, Dongguk University Startup Technology Institute announced the signing of a joint MOU with LifestyledAI Co., Ltd. and UMUST R&D to advance global deep tech and healthcare initiatives through the application of LifestyledAI’s cutting-edge, proprietary AI technologies (patent-pending).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240913711167/en/

Representative of Dongguk University Startup Technology Institute, Jinwan Kim - CEO of LifestyledAI, and Kangpa Lee - CEO of UMUST R&D (from left) (photo: LifestyledAI Co., Ltd.)

Representative of Dongguk University Startup Technology Institute, Jinwan Kim – CEO of LifestyledAI, and Kangpa Lee – CEO of UMUST R&D (from left) (photo: LifestyledAI Co., Ltd.)

With this agreement, the parties plan to promote mutual cooperation with the goals of:

  • Collaborating on AI-based technology development and commercialization
  • Establishing strategies and providing technical support for exploring overseas markets
  • Joint research and development (international joint R&D, workshops, and seminars)
  • Exchanging research personnel
  • Creating an industry-academia cooperation ecosystem for mutual growth

LifestyledAI is an AI deep-tech startup that seeks to revolutionize customer lifestyles through its proprietary AI-based technologies, including AI Ultra-Real Fitting for highly realistic virtual fashion and beauty try-ons, and a precise, easy-to-use AI body measurement system. With a vision to become a global leader in the practical application of AI image technology, LifestyledAI is dedicated to enhancing user convenience in the fashion and beauty e-commerce industries through its innovative AI solutions. As a resident company in Dongguk University’s Startup Incubation Center, it receives extensive support in areas such as international market expansion, industry-academia collaboration, faculty consulting, technology transfer, and commercialization.

UMUST R&D Co., Ltd. is a renowned global healthcare startup focused on the development of global healthcare and AI technologies. Its core areas of expertise include the development of AI-based medical devices and healthcare solutions, leveraging cutting-edge technologies to drive innovation in the medical industry.

Jinwan Kim, CEO of LifestyledAI, stated, “This partnership will allow us to further refine our proprietary AI technologies and accelerate their global commercialization, helping to advance the AI deep-tech and healthcare industries on a global scale.”

Director Gwangho Yoo, Head of Dongguk University Startup Technology Institute, commented, “This agreement will facilitate a collaborative research and development framework in the AI and healthcare sectors by leveraging in-house technologies and matching human resources to strengthen industry-academia collaboration.”

Kangpa Lee, CEO of UMUST R&D, stated, “We are dedicated to advancing the AI image technologies developed by LifestyledAI and working together to implement these innovations in the development of cutting-edge AI medical devices, while also enhancing our global business capabilities.”

View source version on businesswire.com: https://www.businesswire.com/news/home/20240913711167/en/

CONTACT

LifestyledAI Co., Ltd.

Jinwan Kim

jinwan.kim@lifestyled.ai

同じカテゴリーの記事 

  • InnoCare Announces Approval of Clinical Trial of BCL2 Inhibitor ICP-248 for Acute Myeloid Leukemia in China
  • Takeda Commits Over $32 Million in Five New Global Corporate Social Responsibility Partnerships to Further Drive Health Impact in 93 Countries
  • 武田薬品工業: 5つの新しいグローバルCSRパートナーシップに3,200万ドル以上を拠出し、93カ国における健康増進を支援
  • Axcelead DDP and Lilly Enter into Research and Collaboration Agreement
  • GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as Long